3 completed, 1 terminated, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Terminated 1, Unknown 1 |
Follow Disease Susceptibility: new trials by email Literature Review of Disease Susceptibility trials Research Report on Disease Susceptibility
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment Torasemide, Spironolactone - Hypertension, Genetic Predisposition | Phase 3 | Completed | Ospedale San Raffaele | 38 | 2021-02-15 | 2024-05-16 |
| Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer DT group, ET group, NX group - Susceptibility, Genetic, Chemotherapy Effect | Phase 3 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 300 | 2017-12-01 | 2017-12-02 |
| Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. Cloxacilin, Cloxacillin, Levofloxacin - Staphylococcus | Phase 3 | Terminated | Fundación Pública Andaluza Progreso y Salud | 1 | 2013-05-01 | 2015-08-07 |
| Prevention of Obesity in Women Via Estradiol Regulation leuprolide acetate, Estradiol Transdermal, progressive resistance exercise training - Obesity | Phase 3 | Completed | University of Colorado, Denver | 79 | 2008-05-01 | 2025-04-01 |
| Secondary Prevention of Osteoporosis alendronate with cholecalciferol, calcium carbonate with cholecalciferol, Falls prevention measures - Osteoporosis | Phase 3 | Completed | Hebrew SeniorLife | 29 | 2007-02-01 | 2020-02-05 |
Genetic Predisposition to Disease (2) · Breast Neoplasms (1) · Hypertension (1) · Metabolic Syndrome (1) · Obesity (1) · Osteoporosis (1) · Osteoporotic Fractures (1) · Short Stature, Auditory Canal Atresia, Mandibular Hypoplasia, Skeletal Abnormalities (1)
Disease Attributes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Body Weight (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Breast Diseases (1) · Cardiovascular Diseases (1) · Fractures, Bone (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Insulin Resistance (1)
Alendronate (1) · Calcium Carbonate (1) · Canrenoic Acid (1) · Capecitabine (1) · Cholecalciferol (1) · Cloxacillin (1) · Docetaxel (1) · Estradiol (1) · Fumigant 93 (1) · Leuprolide (1) · Levofloxacin (1) · Spironolactone (1) · Torsemide (1) · Vinorelbine (1) · liposomal doxorubicin (1)
Fundación Pública Andaluza Progreso y Salud (1) · Hebrew SeniorLife (1) · Ospedale San Raffaele (1) · Tianjin Medical University Cancer Institute and Hospital (1) · University of Colorado, Denver (1)
United States (2) · China (1) · Italy (1) · Spain (1)
Jin Zhang, Doctor (1) · Paolo Manunta, MD (1) · Sarah D Berry, MD, MPH (1) · Wendy M Kohrt, PhD (1)
R01AG018198 (1), T32AG023480 (1)